These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34170841)

  • 21. AbsorbaSeal™ 5.6.7F vascular closure device: A good laboratory practice chronic study evaluating safety and efficacy in a healthy porcine model.
    Ayuso SA; Shipp RC; Aladegbami BG; Farquharson D; Lawson D; Bassett R
    Vascular; 2022 Oct; 30(5):934-942. PubMed ID: 34459306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and Subclinical Femoral Vascular Complications after Deployment of two Different Vascular Closure Devices or Manual Compression in the Setting of Coronary Intervention.
    Yeni H; Axel M; Örnek A; Butz T; Maagh P; Plehn G
    Int J Med Sci; 2016; 13(4):255-9. PubMed ID: 27076781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practices and complications of vascular closure devices and manual compression in patients undergoing elective transfemoral coronary procedures.
    Smilowitz NR; Kirtane AJ; Guiry M; Gray WA; Dolcimascolo P; Querijero M; Echeverry C; Kalcheva N; Flores B; Singh VP; Rabbani L; Kodali S; Collins MB; Leon MB; Moses JW; Weisz G
    Am J Cardiol; 2012 Jul; 110(2):177-82. PubMed ID: 22482861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Network Meta-analysis of Randomized Trials on the Safety of Vascular Closure Devices for Femoral Arterial Puncture Site Haemostasis.
    Jiang J; Zou J; Ma H; Jiao Y; Yang H; Zhang X; Miao Y
    Sci Rep; 2015 Sep; 5():13761. PubMed ID: 26349075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors related to insufficient hemostasis using the EXOSEAL vascular closure device with five-minutes compression for femoral artery punctures after neuro-endovascular therapy: A retrospective, single-center experience.
    Izawa D; Matsumoto H; Nishiyama H; Nakayama Y; Maeshima K
    Interv Neuroradiol; 2024 Apr; 30(2):255-263. PubMed ID: 36357980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complication rates associated with antegrade use of vascular closure devices: a systematic review and pooled analysis.
    Kennedy SA; Rajan DK; Bassett P; Tan KT; Jaberi A; Mafeld S
    J Vasc Surg; 2021 Feb; 73(2):722-730.e1. PubMed ID: 32950629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic Retrograde Distal Common Femoral Access as a Bail-out Strategy in Patients with Increased Risk for Femoral Access Complication During Transfemoral Aortic Valve Replacement.
    Sanghvi K; Swarup S; Burns P; Kovach R; Ross R; Soussa T
    Cardiovasc Revasc Med; 2020 Apr; 21(4):481-485. PubMed ID: 31375463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of using vascular closure devices for hemostasis on sheath removal after a transfemoral artery percutaneous coronary intervention.
    Su SF; Chang MY; Wu MS; Liao YC
    Jpn J Nurs Sci; 2019 Apr; 16(2):172-183. PubMed ID: 30044037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary Intervention.
    Marquis-Gravel G; Boivin-Proulx LA; Huang Z; Zelenkofske SL; Lincoff AM; Mehran R; Steg PG; Bode C; Alexander JH; Povsic TJ
    J Am Heart Assoc; 2023 Jan; 12(1):e025666. PubMed ID: 36583436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective evaluation of safety and effectiveness of the EXOSEAL vascular closure device for single vascular closure and closure after repeat puncture in diagnostic and interventional radiology: single-center experience.
    Boschewitz JM; Andersson M; Naehle CP; Schild HH; Wilhelm K; Meyer C
    J Vasc Interv Radiol; 2013 May; 24(5):698-702. PubMed ID: 23622041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous access-site closure with vascular closure device vs. manual compression in patients undergoing catheter ablation or left atrial appendage occlusion under uninterrupted anticoagulation: a multicentre experience on efficacy and complications.
    Mohanty S; Trivedi C; Beheiry S; Al-Ahmad A; Horton R; Della Rocca DG; Gianni C; Gasperetti A; Abdul-Moheeth M; Turakhia M; Natale A
    Europace; 2019 Jul; 21(7):1048-1054. PubMed ID: 30726903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of vascular closure devices for femoral venous hemostasis following catheter ablation of atrial fibrillation.
    Mills MT; Calvert P; Lip GYH; Luther V; Gupta D
    J Cardiovasc Electrophysiol; 2024 Aug; 35(8):1656-1662. PubMed ID: 38924288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of vascular closure devices after transbrachial artery access.
    Mirza AK; Steerman SN; Ahanchi SS; Higgins JA; Mushti S; Panneton JM
    Vasc Endovascular Surg; 2014; 48(7-8):466-9. PubMed ID: 25267690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices.
    Duffin DC; Muhlestein JB; Allisson SB; Horne BD; Fowles RE; Sorensen SG; Revenaugh JR; Bair TL; Lappe DL
    J Invasive Cardiol; 2001 May; 13(5):354-62. PubMed ID: 11385148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the boomerang wire vascular access management system versus manual compression alone during percutaneous diagnostic and interventional cardiovascular procedures: The boomerang™ wire vascular access management trial II.
    Goswami NJ; Smalling RG; Sinha S; Gammon RS; Ramaiah VG
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):75-81. PubMed ID: 25599884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes with plug-based versus suture-based vascular closure device after transfemoral transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Sedhom R; Dang AT; Elwagdy A; Megaly M; Elgendy IY; Zahr F; Gafoor S; Mamas M; Elbadawi A
    Catheter Cardiovasc Interv; 2023 Mar; 101(4):817-827. PubMed ID: 36802100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcomes of MANTA vs suture-based vascular closure devices after transcatheter aortic valve replacement: An updated meta-analysis.
    Doshi R; Vasudev R; Guragai N; Patel KN; Kumar A; Majmundar M; Doshi P; Patel P; Shah K; Santana M; Roman S; Vallabhajosyula S; Virk H; Bikkina M; Shamoon F
    Indian Heart J; 2023; 75(1):59-67. PubMed ID: 36640840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective, randomized, pivotal trial of a novel extravascular collagen-based closure device compared to manual compression in diagnostic and interventional patients.
    Hermiller JB; Leimbach W; Gammon R; Karas SP; Whitbourn RJ; Wong SC; Goswami N; McCabe J; Cavros NG; Paulus R; Naidu SS; Turi ZG
    J Invasive Cardiol; 2015 Mar; 27(3):129-36. PubMed ID: 25740963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suture- or Plug-Based Large-Bore Arteriotomy Closure: A Pilot Randomized Controlled Trial.
    van Wiechen MP; Tchétché D; Ooms JF; Hokken TW; Kroon H; Ziviello F; Ghattas A; Siddiqui S; Laperche C; Spitzer E; Daemen J; de Jaegere PP; Dumonteil N; Van Mieghem NM
    JACC Cardiovasc Interv; 2021 Jan; 14(2):149-157. PubMed ID: 33358648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of Vascular Closure Device Use After Transfemoral Coronary Intervention: Insights From the EXCEL Trial.
    Kuno T; Claessen BE; Guedeney P; Serruys PW; Sabik JF; Simonton CA; Kandzari DE; Morice MC; Zhang Z; Dressler O; Mehran R; Ben-Yehuda O; Kappetein AP; Stone GW
    J Invasive Cardiol; 2021 Aug; 33(8):E619-E627. PubMed ID: 34170842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.